Increased detection of cystic-fibrosis-related diabetes in Australia

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 823-826

  Rana, Malay ^a,b   Munns, Craig F ^a,c   Selvadurai, Hiran C ^a,c   Simonds, Sharon ^a   Cooper, Peter J ^a,c   Woodhead, Helen J ^b,d,e   Hameed, Shihab ^b,d   Verge, Charles F ^b,d   Lafferty, Antony R ^f,g   Crock, Patricia A ^h   Craig, Maria E ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SYDNEY CHILDREN'S HOSPITAL   (Australia)

^e CAMPBELLTOWN HOSPITAL   (Australia)

^f CANBERRA HOSPITAL   (Australia)

^g The Australian National University   (Australia)

^h JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; AUSTRALIA; AWARENESS; BODY MASS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; INSULIN TREATMENT; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RURAL AREA; SCREENING;

ADOLESCENT; AUSTRALIAN CAPITAL TERRITORY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; INSULIN; MALE; NEW SOUTH WALES; REGISTRIES;

EID: 80051812022     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.208652     Document Type: Article

References (22)

1. Brennan A.L., Geddes D.M., Gyi K.M., et al. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004;3:209-222 (Pubitemid 40227489)
2. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: Annual Data Report 2007. 2008:1-24.
3. Moran A., Dunitz J., Nathan B., et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631
4. Moran A., Doherty L., Wang X., et al. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998;133:10-17. (Pubitemid 28323899)
5. van den Berg J.M., Kouwenberg JM, Heijerman HG. Demographics of glucose metabolism in cystic fibrosis. J Cyst Fibros 2009;8:276-279
6. Lanng S., Thorsteinsson B., Lund-Andersen C., et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994;83:72-77 (Pubitemid 24072085)
7. Dobson L., Sheldon CD, Hattersley AT. Understanding cystic-fibrosis- related diabetes: best thought of as insulin deficiency? J R Soc Med 2004;97(Suppl 44):26-35. (Pubitemid 38680171)
8. Marshall B.C., Butler S.M., Stoddard M., et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005;146:681-687 (Pubitemid 40616255)
9. Lanng S., Hansen A., Thorsteinsson B., et al. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995;311:655-659
10. Adler A I, Shine B.S., Chamnan P., et al. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008;31:1789-1794
11. Bismuth E, Laborde K, Taupin P, et al Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis J Pediatr 2008;152:540-5, 545.e1.
12. O'Riordan S.M., Robinson P.D., Donaghue K.C., et al. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 2009;10(Suppl 12):43-50.
13. LaPorte R.E., McCarty D., Bruno G., et al. Counting diabetes in the next millennium. Application of capture-recapture technology. Diabetes Care 1993;16:528-534 (Pubitemid 23046647)
14. Cystic Fibrosis Australia. Cystic Fibrosis in Australia 2007: 10th Annual Report from the Australian Cystic Fibrosis Data Registry. 2009:1-57.
15. Rosan R.C., Shwachman H, Kulczvcki LI. Diabetes mellitus and cystic fibrosis of the pancreas. Laboratory and clinical observations. Am J Dis Child 1962;104:625-634
16. Smith A, Bergman P, Armstrong D, Cystic fibrosis related diabetes screening practices in Australia and New Zealand Poster presented at The Transplantation Society of Australia and New Zealand Conference, August 2008, Sydney, Australia.
17. Walshaw M. Routine OGTT screening for CFRD-no thanks. J R Soc Med 2009;102(Suppl 1):40-44
18. Peckham D. Routine screening for cystic fibrosis-related diabetes. J R Soc Med 2009;102(Suppl 1):36-39
19. Craig M.E., Howard N.J., Silink M., et al. The rising incidence of childhood type 1 diabetes in New South Wales, Australia. J Pediatr Endocrinol Metab 2000;13:363-372 (Pubitemid 30202252)
20. Rana M., Munns C.F., Selvadurai H., et al. Cystic fibrosis-related diabetes in children-gaps in the evidence? Nat Rev Endocrinol 2010;6:371-378
21. Minicucci L., Cotellessa M., Pittaluga L., et al. Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis. J Pediatr Endocrinol Metab 2005;18:755-760 (Pubitemid 41309338)
22. Onady G.M., Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005;3:CD004730.